Perttu J Lindsberg1,2, Tiina Sairanen1, Simon Nagel3, Oili Salonen4, Heli Silvennoinen4, Daniel Strbian1. 1. Clinical Neurosciences, Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. 2. Molecular Neurology, Research Programs Unit, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland. 3. Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany. 4. Helsinki Medical Imaging Center, Helsinki University Central Hospital, Helsinki, Finland.
Abstract
BACKGROUND AND AIMS: Basilar artery occlusion is a most devastating form of stroke, and the current practice is to reverse it with revascularization therapies. Pharmacological thrombolysis, intravenous or intraarterial, has been adjuncted or replaced with invasive, endovascular thrombectomy procedures. The preferred approach remains unknown and many recanalizations are futile with no clinical benefit. We sought to determine reasons for futility and weigh the existing reports to find whether endovascular mechanical interventions provide superior outcomes over pharmacological thrombolysis alone. METHODS: After analyzing systematically the reports of outcomes produced by variable basilar artery occlusion recanalization protocols, information was retrieved and reconciled from 15 reports published from year 2005 comprising 803 patients in 17 cohorts. In the largest single-center cohort (162, Helsinki), predictors of futile recanalization (three-month modified Rankin Scale score 4 to 6) were determined. RESULTS: Good outcome was reported by mechanical approaches either alone or on demand more frequently than by pharmacological, intravenous or intraarterial thrombolysis protocols (35.5% versus 24.4%, p < 0.001), accompanied by higher recanalization rates (84.1% versus 70.9%, p < 0.001). Along with superior recanalization rate at 91%, good outcome was reached by primary thrombectomy in 36% at the cost of substantial futile recanalization rate at 60%, which was lower when using modern stentrievers only (52.8%). In the Helsinki cohort, the single most significant predictor was extensive baseline ischemia, increasing the odds of futility 20-fold (95%CI 4.39-92.29, p < 0.001). Other attributes of futility were ventilation support and history of atrial fibrillation or previous stroke. CONCLUSIONS: Endovascular mechanical approaches have been reported to provide superior outcomes over pharmacological thrombolysis in basilar artery occlusion. Stricter patient selection, most notably to exclude victims of already extended ischemia, would assist in translating excellent recanalization rates into improved clinical outcomes and more acceptable futility rates.
BACKGROUND AND AIMS: Basilar artery occlusion is a most devastating form of stroke, and the current practice is to reverse it with revascularization therapies. Pharmacological thrombolysis, intravenous or intraarterial, has been adjuncted or replaced with invasive, endovascular thrombectomy procedures. The preferred approach remains unknown and many recanalizations are futile with no clinical benefit. We sought to determine reasons for futility and weigh the existing reports to find whether endovascular mechanical interventions provide superior outcomes over pharmacological thrombolysis alone. METHODS: After analyzing systematically the reports of outcomes produced by variable basilar artery occlusion recanalization protocols, information was retrieved and reconciled from 15 reports published from year 2005 comprising 803 patients in 17 cohorts. In the largest single-center cohort (162, Helsinki), predictors of futile recanalization (three-month modified Rankin Scale score 4 to 6) were determined. RESULTS: Good outcome was reported by mechanical approaches either alone or on demand more frequently than by pharmacological, intravenous or intraarterial thrombolysis protocols (35.5% versus 24.4%, p < 0.001), accompanied by higher recanalization rates (84.1% versus 70.9%, p < 0.001). Along with superior recanalization rate at 91%, good outcome was reached by primary thrombectomy in 36% at the cost of substantial futile recanalization rate at 60%, which was lower when using modern stentrievers only (52.8%). In the Helsinki cohort, the single most significant predictor was extensive baseline ischemia, increasing the odds of futility 20-fold (95%CI 4.39-92.29, p < 0.001). Other attributes of futility were ventilation support and history of atrial fibrillation or previous stroke. CONCLUSIONS: Endovascular mechanical approaches have been reported to provide superior outcomes over pharmacological thrombolysis in basilar artery occlusion. Stricter patient selection, most notably to exclude victims of already extended ischemia, would assist in translating excellent recanalization rates into improved clinical outcomes and more acceptable futility rates.
Authors: Nils Wahlgren; Niaz Ahmed; Antoni Dávalos; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Sonja Kuelkens; Vincent Larrue; Kennedy R Lees; Risto O Roine; Lauri Soinne; Danilo Toni; Geert Vanhooren Journal: Lancet Date: 2007-01-27 Impact factor: 79.321
Authors: Perttu J Lindsberg; Lauri Soinne; Turgut Tatlisumak; Risto O Roine; Mikko Kallela; Olli Häppölä; Markku Kaste Journal: JAMA Date: 2004-10-20 Impact factor: 56.272
Authors: Simon Nagel; Peter D Schellinger; Marius Hartmann; Eric Juettler; Hagen B Huttner; Peter Ringleb; Stefan Schwab; Martin Köhrmann Journal: Stroke Date: 2008-10-16 Impact factor: 7.914
Authors: Wouter J Schonewille; Christine A C Wijman; Patrik Michel; Christina M Rueckert; Christian Weimar; Heinrich P Mattle; Stefan T Engelter; David Tanne; Keith W Muir; Carlos A Molina; Vincent Thijs; Heinrich Audebert; Thomas Pfefferkorn; Kristina Szabo; Perttu J Lindsberg; Gabriel de Freitas; L Jaap Kappelle; Ale Algra Journal: Lancet Neurol Date: 2009-07-03 Impact factor: 44.182
Authors: Volker Puetz; P N Sylaja; Shelagh B Coutts; Michael D Hill; Imanuel Dzialowski; Pia Mueller; Ulf Becker; Gabriele Urban; Christine O'Reilly; Philip A Barber; Pranshu Sharma; Mayank Goyal; Georg Gahn; Ruediger von Kummer; Andrew M Demchuk Journal: Stroke Date: 2008-07-10 Impact factor: 7.914
Authors: Charlotte S Weyland; Ulf Neuberger; Arne Potreck; Johannes A R Pfaff; Simon Nagel; Silvia Schönenberger; Martin Bendszus; Markus A Möhlenbruch Journal: Clin Neuroradiol Date: 2020-09-07 Impact factor: 3.649
Authors: Thomas Meinel; Christine Lerch; Urs Fischer; Morin Beyeler; Adnan Mujanovic; Christoph Kurmann; Bernhard Siepen; Adrian Scutelnic; Madlaine Müller; Martina Goeldlin; Nebiyat Filate Belachew; Tomas Dobrocky; Jan Gralla; David Seiffge; Simon Jung; Marcel Arnold; Roland Wiest; Raphael Meier; Johannes Kaesmacher Journal: Neurology Date: 2022-07-08 Impact factor: 11.800
Authors: Thomas Raphael Meinel; Johannes Kaesmacher; Pascal John Mosimann; David Seiffge; Simon Jung; Pasquale Mordasini; Marcel Arnold; Martina Goeldlin; Steven D Hajdu; Marta Olivé-Gadea; Christian Maegerlein; Vincent Costalat; Laurent Pierot; Joanna D Schaafsma; Urs Fischer; Jan Gralla Journal: Neurology Date: 2020-08-26 Impact factor: 9.910